Larger doses of radiotherapy have been linked to hormone deficiencies in young patients treated for brain tumors, according to research published Aug. 17 in the Journal of Clinical Oncology.

The National Electrical Manufacturers Association (NEMA) president and CEO, Kevin J. Cosgriff testified Aug. 21 at a public hearing by the Office of U.S. Trade Representatives (USTR) to voice the concerns of member companies regarding potential additional tariffs on $200 billion in Chinese goods—including medical imaging products.

In fiscal year 2017, the Medicaid program doled out about $37 billion in improper payments, an increase from $29.1 billion in improper payments recorded in 2015, according to a report from the Government Accountability Office.

Planning around staff shortages in radiology might seem like a future inevitability for departmental directors, British researchers wrote in a Radiography study published this month. But employees’ greatest source of psychological stress doesn’t stem from a lack of colleagues—it comes from the uncertainty of a constantly shifting job market.

Researchers from Cleveland Clinic have discovered a new subtype of multiple sclerosis (MS), according to research published in Lancet Neurology. These findings, they said, highlight the importance of developing more sensitive imaging techniques for real-time evaluations of brain pathology.

Physicians who have a personal connection to cancer are nearly 18 percent more likely to act against established guidelines and recommend cancer screening for low-risk patients, specifically ovarian cancer screening in women, according to the Journal of Women’s Health.  

One Medical Group, a primary care group with offices in San Francisco, New York, Seattle and other cities, has closed a $350 million investment from the Carlyle Group, a private equity group based in Washington, D.C., TechCrunch reported.

Medicare could be saving a lot of cash by switching to generic constituents for some drugs—maybe as much as a billion dollars.
A recent study estimated spending in 2016 on 29 brand-name combination products would have been $925 million more than spending for generic counterparts.